Isotechnika gets 'no objection letter' from Health Canada for psoriasis trial

EDMONTON (CP) - Drug developer Isotechnika Inc. said Wednesday it has received a "no objection letter" from Health Canada for the start of a Phase 3 trial for its treatment of psoriasis. Trading in Isotechnika shares was halted pending the announcement....More